Removable Walker for Neuropathic Ulcers
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
- Objective: To evaluate the efficacy of removable cast walker compared to non-removable fiberglass off-bearing cast in the treatment of diabetic plantar foot ulcer
- Research design and methods: Forty-five adult diabetic patients with non-ischemic, non-infected neuropathic plantar ulcer were randomized to treatment with a non-removable fiberglass off-bearing cast (TCC group) or walker cast (Stabil-D group). Treatment duration was 90 days. Percent reduction in ulcer surface area and total healing rates were evaluated after treatment.
| Condition | Intervention | Phase |
|---|---|---|
|
Diabetic Foot |
Device: non-removable fiberglass Device: Stabil-D® |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Effectiveness of Removable Walker Cast Versus Non-removable Fiberglass Off-bearing Cast in the Healing of Diabetic Plantar Foot Ulcer- a Randomized Controlled Trial |
- Decrease in ulcer size [ Time Frame: at 90th day ] [ Designated as safety issue: Yes ]
- Complete healing rate at the end of the study [ Time Frame: at 90th day ] [ Designated as safety issue: Yes ]
| Enrollment: | 48 |
| Study Start Date: | February 2008 |
| Study Completion Date: | March 2009 |
| Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: non-removable fiberglass
Softcast3M®, 3M Health Care, St. Paul, MN (USA) were used for construction of the pressure-relief apparatus
|
Device: non-removable fiberglass
Two types of fiberglass bandages (Softcast3M®, 3M Health Care, St. Paul, MN (USA)) were used for construction of the pressure-relief apparatus
Other Name: Softcast3M®, 3M Health Care, St. Paul, MN (USA)
|
|
Active Comparator: Stabil-D®
Composed of a specifically designed rigid, boat shaped, and fully rocker bottom sole
|
Device: Stabil-D®
Stabil-D Stabil-D® is composed of a specifically designed rigid, boat shaped, and rocker sole
Other Name: Podartis srl, Montebelluna, Treviso, Italy
|
Detailed Description:
Study design:
Two centers specializing in diabetic foot management (located in Sesto S. Giovanni and Milan, Italy) participated to this open, randomized clinical trial. The ethics-committee approved the study on January 10th, 2008. Enrollment of consecutive patients began February 2008 and ended March 2009. Eligible patients were fully informed of the study aim and procedures and written consent was obtained prior to study participation. Patients were then randomly assigned to one of the two treatment groups by opening randomization codebreak envelopes containing one of the two options. Separate randomization was performed for each center, and a copy of all randomization envelopes was kept at the statistical department of the Multimedica center. The two arms were composed of patients managed with non-removable fiberglass off-bearing cast (TCC group) and patients offloaded with the Stabil-D® (Podartis srl, Montebelluna, Treviso, Italy) walker cast (Stabil-D group).
Eligibility| Ages Eligible for Study: | 18 Years to 80 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The presence of neuropathic plantar ulcer with an area graded IA according to the Texas University classification, AND
- The presence of peripheral neuropathy. Peripheral neuropathy was diagnosed based on insensitivity to a 10-g Semmes-Weinstein monofilament in more than 6 out of 9 areas of the foot and by a vibration perception threshold measured by biothesiometer (Neurothesiometer SLS, Nottingham, UK) at the malleolus > 25 volts.
Exclusion Criteria:
- Presence of an ankle-brachial pressure index (ABI) < 0.9 and/or transcutaneous oxygen tension (TcPO2) < 50 mmHg tested on the dorsum of the foot,
- Presence of clinical signs of infection, including edema, erythema, increased local skin temperature, or drainage,
- The probe-to-bone maneuver was required to be negative,
- Tthe standard X-ray examination of the foot was required to be negative for osteomyelitis,
- Use of steroids or cytostatic drugs,
- Presence of sensory, motor, or visual problems that could impair functional autonomy,
- Active ulcer on the contralateral foot,
- Previous major amputation of the contralateral limb,
- Previous or current deep venous leg thrombosis, OR
- Mental disorders interfering with patient compliance.
Contacts and Locations| Italy | |
| Diabetic Foot Center - IRCCS Multimedica | |
| Sesto San Giovanni, Milan, Italy, 20099 | |
| Principal Investigator: | Ezio Faglia, MD | Diabetic Foot Center - IRCCS Multimedica, Sesto San Giovanni (Milan), Italy |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Ezio Faglia MD, Diabetic Foot Center - IRCCS Multimedica, Sesto San Giovanni (Milan), Italy |
| ClinicalTrials.gov Identifier: | NCT01005264 History of Changes |
| Other Study ID Numbers: | 05/2007cardiovascolare |
| Study First Received: | October 19, 2009 |
| Last Updated: | October 29, 2009 |
| Health Authority: | Italy: The Italian Medicines Agency |
Keywords provided by IRCCS Multimedica:
|
diabetic foot neuropathic plantar ulcer ulcer healing non-removable total contact cast removable cast walker |
Additional relevant MeSH terms:
|
Ulcer Diabetic Foot Pathologic Processes Diabetic Angiopathies Vascular Diseases Cardiovascular Diseases Foot Ulcer |
Leg Ulcer Skin Ulcer Skin Diseases Diabetes Complications Diabetes Mellitus Endocrine System Diseases Diabetic Neuropathies |
ClinicalTrials.gov processed this record on June 13, 2013